|
See related Cervarix[保蓓] information |
|
|
|
製造商 |
GlaxoSmithKline |
|
代理/經銷商 |
GlaxoSmithKline |
|
成份 |
Per 0.5 mL Human papillomavirus virus type 16 L1 protein 20 mcg. human papillomavirus virus type 18 L1 protein 20 mcg |
|
適應症 |
Prevention of cervical cancer in females 10-25 years, by protecting against incident & persistent infections, cytological abnormalities including atypical squamous cells of undetermined significance (ASC-US) & cervical intraepithelial neoplasia (CIN), CIN1 & pre-cancerous lesions (CIN2 & CIN3) caused by HPV Types 16 & 18. |
|
用量 |
0.5 mL IM in the deltoid region at 0, 1, 6 month. |
|
過量 |
View Cervarix[保蓓] overdosage for action to be taken in the event of an overdose. |
|
美國食品藥物管理局之懷孕等級 |
Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters). |
|
禁忌 |
[Click for Cervarix[保蓓] detailed prescribing infomation] |
|
注意事項 |
Acute severe febrile illness, thrombocytopenia, coagulation disorder, impaired immunity, concomitant immunosuppressants. Not for treatment of cervical cancer, cervical dysplastic lesions or prevention of progression of other HPV-related lesions present at time of vaccination. Pregnancy & lactation. |
|
不良反應 |
Headache, GI disturbances, itch, rash, myalgia, arthralgia, inj site reactions, fatigue, fever.
View ADR Monitoring Website[參閱藥物不良反應監測表格] |
|
交互作用 |
[Click for Cervarix[保蓓] detailed prescribing infomation]
View more drug interactions with Cervarix[保蓓] |
|
使用上注意 |
For caution against possible variation of physical aspect of medicine... click to view Cervarix[保蓓] detailed prescribing infomation |
|
儲存 |
View Cervarix[保蓓] storage conditions for details to ensure optimal shelf-life. |
|
描述 |
View Cervarix[保蓓] description for details of the chemical structure and excipients (inactive components). |
|
作用 |
View Cervarix[保蓓] mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
本商品之市售規格 |
|
劑型 |
包裝 |
圖片 |
|
Cervarix 注射劑 |
|
|
Cervarix 筆式注射劑 |
|
|
|
Manufacturer: |
GlaxoSmithKline |
|
Distributor: |
GlaxoSmithKline |
|
 |
|
|
|
